RxDoctor Payments DataLook up a doctor →

Piotr Lazowski, MD

Nephrology · Plymouth, MANPI 1386691012

Payments from drug & device makers

$529,833in general payments, 2019–2025

Across 465 payments — averaging $1139.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Akebia Therapeutics Inc$448K
  • Astrazeneca AB$79K
  • AstraZeneca$3K
  • Amgen$129
  • Novo Nordisk$120
  • Novartis$80
  • plus $400 from 16 others

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$529,833 in reported general payments places this provider in the 90th percentile of 339 nephrology providers in Massachusetts.

See all nephrology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$666,291
Medicare patients
1,215
Services billed
6,420

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Plymouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →